These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study. Farish E; Barnes JF; Rankin M; Hart DM Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769 [TBL] [Abstract][Full Text] [Related]
24. [Oral hormone therapy in pre- and postmenopause]. Braendle W Med Klin (Munich); 1990 Apr; 85(4):200-5. PubMed ID: 2191210 [No Abstract] [Full Text] [Related]
25. [Management of the climacteric syndrome exemplified by ambulatory care of menopause at the 1st University Gynecologic Clinic]. Metka M Gynakol Rundsch; 1987; 27(4):252-6. PubMed ID: 2830178 [No Abstract] [Full Text] [Related]
27. [Hormone substitution in climacteric. Position of the German Menopause Society]. Schneider HP; Kuhl H; Dören M; Hesch D Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352 [No Abstract] [Full Text] [Related]
28. [Transdermal and oral hormone substitution with estrogens: a comparison]. Schindler AE Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831 [TBL] [Abstract][Full Text] [Related]
29. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery. Baker VL Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545 [TBL] [Abstract][Full Text] [Related]
31. Gynecologic problems of menopausal women: part 2. Treating estrogen deficiency. Notelovitz M Geriatrics; 1978 Sep; 33(9):35-7, 41-2. PubMed ID: 680564 [No Abstract] [Full Text] [Related]
32. [Hepatic changes in different hormone replacement therapies in climacteric]. Foth D; Römer T; Panzig E Zentralbl Gynakol; 1995; 117(7):349-52. PubMed ID: 7668064 [TBL] [Abstract][Full Text] [Related]
33. [The current principles of the hormonal therapy of patients with the climacteric syndrome]. Gudkova MA Akush Ginekol (Mosk); 1994; (2):7-11. PubMed ID: 8017586 [No Abstract] [Full Text] [Related]
36. [A new synthetic estrone derivative for the treatment of climacteric disorders]. Cyran W Med Welt; 1979 Mar; 30(10):384-8. PubMed ID: 368495 [No Abstract] [Full Text] [Related]
37. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch]. Sajtos B; Herold J; Winkler UH; Schindler AE Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835 [TBL] [Abstract][Full Text] [Related]
38. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause]. Rachev E Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531 [TBL] [Abstract][Full Text] [Related]
39. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints]. Tsvetkov Ts; Tsvetkov K; Petkova U Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312 [No Abstract] [Full Text] [Related]
40. [The climacteric and its hormonal treatment]. Gvorgiev DB Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]